4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the FDA this week.

Advertisement

1. Trogarzo is an antiretroviral medication for adult HIV patients who do not respond to other HIV therapies on the market.

2. The Masters Series Mechanical Heart Valve is now available in a 15 millimeter size for use in newborns with heart defects.

3. Oxford Immunotec’s new detection tests screen for Babesia microti— a parasite transmitted via deer ticks — in samples of donated blood.

4. 23andMe’s direct-to-consumer breast cancer test screens for three specific BRCA1 and BRCA2 breast cancer gene mutations.

More articles on supply chain:
Teva shutters offices in New York City, Washington D.C., as part of cost cutting plan
AbbVie, Biogen pull multiple sclerosis drug from the market citing safety concerns: 4 things to know
Amazon ‘poaches’ 20 jobs from CVS, Express Scripts, UnitedHealth: 6 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.